US Patent 10966412 Animal models and therapeutic molecules
Patent 10966412 was granted and assigned to Kymab on April, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 11, 2018
Date of Patent
April 6, 2021
Patent Applicant
Patent Application Number
16216666
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10966412 Animal models and therapeutic molecules
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
